André R Belisário,Anna B Carneiro-Proietti,Ester Cerdeira Sabino,Aderson Araújo,Paula Loureiro,Cláudia Máximo,Miriam V Flor-Park,Daniela D O W Rodrigues,Mina Cintho Ozahata,Christopher McClure,Rosimere Afonso Mota,Isabel C Gomes Moura,Brian Custer,Shannon Kelly,Recipient Epidemiology and Donor Evaluation Study (REDS-III) International Component Brazil

Abstract:We described the clinical, laboratory and molecular characteristics of individuals with Hb S (HBB: c.20A>T)/β-thalassemia (Hb S/β-thal) participating in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) Brazil Sickle Cell Disease cohort. HBB gene sequencing was performed to genotype each β-thal mutation. Patients were classified as Hb S/β0-thal, Hb S/β+-thal-severe or Hb S/β+-thal based on prior literature and databases of hemoglobin (Hb) variants. Characteristics of patients with each β-thal mutation were described and the clinical profile of patients grouped into Hb S/β0-thal, Hb S/β+-thal and Hb S/β+-thal-severe were compared. Of the 2793 patients enrolled, 84 (3.0%) had Hb S/β0-thal and 83 (3.0%) had Hb S/β+-thal; 40/83 (48.2%) patients with Hb S/β+-thal had mutations defined as severe. We identified 19 different β-thal mutations, eight Hb S/β0-thal, three Hb S/β+-thal-severe and eight Hb S/β+-thal. The most frequent β0 and β+ mutations were codon 39 (HBB: c.118C>T) and IVS-I-6 (T>C) (HBB: c.92+6T>C), respectively. Individuals with Hb S/β0-thal had a similar clinical and laboratory phenotype when compared to those with Hb S/β+-thal-severe. Individuals with Hb S/β+-thal-severe had significantly lower total Hb and Hb A levels and higher Hb S, white blood cell (WBC) count, platelets and hemolysis markers when compared to those with Hb S/β+-thal. Likewise, individuals with Hb S/β+-thal-severe showed a significantly higher occurrence of hospitalizations, vaso-occlusive events (VOE), acute chest syndrome (ACS), splenic sequestration, blood utilization, and hydroxyurea (HU) therapy.

Splice Acceptor Mutation [HBB:c.93-2A > T] in a Patient with Hb S/β0-Thalassemia

Hydrops Fetalis Associated with Compound Heterozygosity for Hb Zurich-Albisrieden (HBA2: C.178G > C) and the Southeast Asian (- - SEA /) Deletion.

A new mutation in IVS-1 of the human β globin gene causing β thalassemia due to abnormal splicing

β0-Thalassemia Caused by a Novel Nonsense Mutation

A Triple-Heterozygous Β-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel Β0 Mutation [an IVS-II-654 (C>T) Mutation with a Hb Zürich-Langstrasse (HBB: C.151a>t) Mutation in Cis]

A single-base change at a splice site in a β0-thalassemic gene causes abnormal RNA splicing

Homozygous mild beta-thalassaemia promoter transversion -71 C>T HBB:c.-121 C>T

A novel double heterozygote of HBB c.[219T ＞A;220G ＞T]: gene diagnosis and pedigree analysis

Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes

Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia

First Detection of the Splice Donor Site IVS-I-2 (T-->B) Beta-Thalassemia Mutation in a Chinese Patient.

Identification of a Novel Β-Thalassemia Mutation at Codon 130 (+T) (HBB: C.391inst) in Han Chinese.

De Novo HBB Frameshift Mutation in a Patient with Dominant Β‐thalassemia Major

Hb S/ β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics

Homozygous Mutation on the β-Globin Polyadenylation Signal in a Tunisian Patient with β-Thalassemia Intermedia and Coinheritance of Gilbert's Syndrome

Characterization of a novel HBB:c.194dup variant of the β-globin gene combined with six alpha genes

The Effect of HBB: c.-121C>T Variant [-71 (C>T)] on the β-Globin Promoter: Case Series Study

Editing Aberrant Splice Sites Efficiently Restores Β-Globin Expression in Β-Thalassemia

Unravelling the Complexity of the +33 C>G [HBB:c.-18C>G] Variant in Beta Thalassemia

Severe Thalassemia Caused by Hb Zunyi [β147(HC3)Stop→Gln; HBB: c.442T>C)] on the β-Globin Gene

Novel Promoter Mutation (HBB:C.-139_-138del) Associated with β-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China